Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/16/2003US6664052 Genetic polymorphism in a complement receptor
12/16/2003US6664051 Fixation of nucleotide derivatives to solid carrier
12/16/2003US6664050 Assaying a sample using an antibody specific to an adenovirus type 36p to test for the presence of the adenovirus; thus testing whether the person has been or is infected with adenovirus type 36p
12/16/2003US6664048 Combination of selection steps used to detect clones that express interacting molecules from false positive clones.
12/16/2003US6664047 Aza-benzazolium containing cyanine dyes
12/16/2003US6664043 Detectable chemiluminescent acridinium ester label, comprising an acridinium ester with a hydrophilic modifier
12/16/2003US6664042 Determining viral load in double negative T cells
12/16/2003US6664041 Method for preparing a viral extract containing HIV-II RNA
12/16/2003US6664039 Having very long chain fatty acid coA synthetase activity; identifying a compound that inhibits the thioesterification activity of VLCFA coA-syn
12/16/2003US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid
12/16/2003US6663866 Radioiodinated residualizing antibody conjugates are stable in vivo and used for radoioimmunodetection and radioimmunotherapy, carbohydrates and peptides
12/16/2003US6663837 Achieving electrical connection between biological chip and connecting device accessible on box and obtaining optimum protection of chip with respect to given environment; molecular analysis of DNA
12/16/2003US6663835 Apparatus including conduit for admitting, transporting, and discharging fluid to reservoir for collection at rate of flow limited by conduit; when reservoir is full, fluid rapidly wicks into capillary test space for exposure to test reagents
12/16/2003US6663833 Precise dimensions and geometries of fluid channel precisely control flow rate and provide for mixing and incubation conditions allowing critical reactions to reach equilibrium; membrane detection strip captures products of completed tests
12/16/2003US6663831 Drug screening; for analysis of saliva, sweat, urine, blood and other bodily fluids
12/16/2003US6662653 Sensor assemblies and methods of securing elongated members within such assemblies
12/16/2003US6662646 Test tumbler in a color test machine
12/16/2003US6662635 Method for evaluating a test fluid
12/16/2003US6662629 Propellant test apparatus and method
12/16/2003US6662439 Ablating through metallic layer to form an interlacing electrode pattern; forming into an electrochemical biosensor strip
12/16/2003CA2214359C Dna diagnostics based on mass spectrometry
12/16/2003CA2202167C Molecular tagging system
12/16/2003CA2165343C A method and apparatus for calculating a coagulation characteristic of a sample of blood, a blood fraction or a control
12/16/2003CA2144766C Determination of the extent of cross-linking prior to the intentional curing of polymers
12/16/2003CA2134751C Monoclonal antibodies and their use
12/16/2003CA2127899C Method and apparatus for determining platelet function in primary hemostasis
12/16/2003CA2093196C Electrical sensor for sensing moisture in soils
12/14/2003CA2432496A1 Diagnostic and therapeutic uses of sufu gene
12/11/2003WO2003103017A2 Method and system of determining chamber seasoning condition by optical emission
12/11/2003WO2003102627A1 Differential indication of labeled molecules
12/11/2003WO2003102606A1 Material segregation, density, and moisture analyzing apparatus and method
12/11/2003WO2003102596A1 Cholesterol detection reagent
12/11/2003WO2003102595A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
12/11/2003WO2003102594A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 2 (sstr2)
12/11/2003WO2003102593A1 Methods for avoiding renal injury
12/11/2003WO2003102592A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
12/11/2003WO2003102590A1 Methods of detecting target molecules and molecular in teractions
12/11/2003WO2003102589A1 Method and system for analysis of cancer biomarkers using proteome image mining
12/11/2003WO2003102588A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/11/2003WO2003102587A1 Disc1 partners
12/11/2003WO2003102586A1 Method for diagnosing sepsis by determining anti-asialoganglioside antibodies
12/11/2003WO2003102585A2 Biomolecular kinetics method using a flow-through microarray
12/11/2003WO2003102584A2 Semaphorin-like proteins and methods of using same
12/11/2003WO2003102582A1 Method for detecting biochemical reagin biochip
12/11/2003WO2003102581A2 Assay for glycosylated proteins
12/11/2003WO2003102580A1 Method of coupling binding agents to a substrate surface
12/11/2003WO2003102579A2 Method of screening groups of radioactive molecules and applications thereof
12/11/2003WO2003102578A2 High throughput cellular response assay using microarrays
12/11/2003WO2003102577A1 Cartridge arrangement, fluid analyzer arrangement, and methods
12/11/2003WO2003102576A1 POLYUBIQUITINATION OF RB CATALYZED BY Mdm2
12/11/2003WO2003102575A1 Measuring nitric oxide in blood gases and treatments based thereon
12/11/2003WO2003102572A2 Mass spectrometry
12/11/2003WO2003102567A1 Assembly from a structural element and a control element, method for producing said assembly and use thereof
12/11/2003WO2003102560A1 Multifunctional self-diagnostic device for in-home health-checkup
12/11/2003WO2003102556A1 Analysis device and analysis disc used for the same
12/11/2003WO2003102552A1 Friction sensor
12/11/2003WO2003102547A2 Methods and articles for high throughput analysis of biomolecular interactions
12/11/2003WO2003102546A2 Method and apparatus for detecting substances of interest
12/11/2003WO2003102544A2 Assays for measuring matrix metalloproteinase activities
12/11/2003WO2003102542A2 Comparative proteomics of progressor and nonprogressor populations
12/11/2003WO2003102541A2 Universal biosensor and methods of use
12/11/2003WO2003102539A2 Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
12/11/2003WO2003102246A1 Dot-elisa for the detection of animal viruses
12/11/2003WO2003102241A1 Integrated micro array system and methods therefor
12/11/2003WO2003102234A1 Method for high-throughput integrated chemical and biochemical reactions
12/11/2003WO2003102230A1 Pthrp-based prediction and diagnosis of bone disease
12/11/2003WO2003102227A1 Gene expression and multiple sclerosis
12/11/2003WO2003102225A1 Destructible surfactants and uses thereof
12/11/2003WO2003102222A2 Continuous-flow enzyme assay with mass spectrometry detection
12/11/2003WO2003102221A1 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system
12/11/2003WO2003102220A2 Methods for high throughput and quantitative proteome analysis
12/11/2003WO2003102218A2 Hybrid microcantilever sensors
12/11/2003WO2003102215A2 Methods of identifying and isolating stem cells and cancer stem cells
12/11/2003WO2003102211A2 Method of detecting dna variation in sequence data
12/11/2003WO2003102208A2 Rapid detection of bt-cry toxins
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102182A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof
12/11/2003WO2003102181A1 Method of detecting gene polymorphism
12/11/2003WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION
12/11/2003WO2003102176A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003WO2003102173A2 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances
12/11/2003WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003WO2003102161A2 Methods of diagnosing & treating diabetes and insulin resistance
12/11/2003WO2003102158A2 Methods for increasing bone density
12/11/2003WO2003102157A2 Synthetic antibody phage libraries
12/11/2003WO2003102156A2 Heterologous stimulus-gated ion channels and methods of using same
12/11/2003WO2003102154A2 Improved receptor detection
12/11/2003WO2003102153A2 Cell migration inhibiting compositions and methods and compositions for treating cancer
12/11/2003WO2003102143A2 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1)
12/11/2003WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003WO2003102127A2 Human 5-ht7 receptor promoter sequence
12/11/2003WO2003102126A1 A method of cell therapy using fused cell hybrids
12/11/2003WO2003102125A1 Electrofusion of cells and apparatus therefore
12/11/2003WO2003102124A2 Method and apparatus for measuring nitric oxide production and oxygen consumption in cultures of adherent cells
12/11/2003WO2003102029A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion
12/11/2003WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003WO2003102023A1 Tumour-associated peptides that bond to mhc molecules
12/11/2003WO2003102022A1 Use of reagent homologs for comparative proteomics
12/11/2003WO2003102018A2 Methods for quantitative proteome analysis of glycoproteins
1 ... 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 ... 3937